|
|
|
GBP Capital News |
| May 18, 2010 |
|
| Lentigen Awarded Phase I STTR Grant for Hunter Syndrome |
|
|
GAITHERSBURG, Md.,
May 18 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business technology transfer (STTR) g Read More... |
|
| Filed Under: GBP Captial News |
| May 04, 2010 |
|
| Lentigen Spurring Innovation in AIDS Vaccine Development |
|
|
WASHINGTON, D.C. – As Tim Ravenscroft reflected on the lessons he’s learned during decades in the pharmaceutical, biotech and HIV/AIDS fields at a recent Congressional Biomedical Research Caucus briefing on Capitol Hill, two of his statements reverberated in my mind:
First, there Read More... |
|
| Filed Under: GBP Captial News |
| Mar 17, 2010 |
|
| The Flexstent Femoropopliteal Self-Expanding Stent |
|
|
When lifestyle changes and/or medication alone are not an effective treatment for peripheral artery disease (PAD), endovascular or surgical procedures become an option. Endovascular devices and surgical treatment for PAD represent a major challenge for physicians treating superfi Read More... |
|
| Filed Under: GBP Captial News |
8 results: 1 |
|
|
|
|
